David Vanderstraeten advises and represents Belgian and foreign companies on all aspects of corporate law, with a focus on M&A, private equity and venture capital transactions, and corporate restructurings and reorganizations.
Recent key representations include the acquisition of HistoGeneX and Caprion Biosciences by Arsenal Capital Partners, the Series B financing round of Qover SA led by Alven Capital, and the acquisition of the Bricsys group by Hexagon.
Prior to joining Jones Day in 2018, David worked for another international law firm, where he gained experience in the banking and financial regulation area.
- The London School of Economics and Political Science (LL.M. 2015); University of Ghent (J.D. magna cum laude 2014); University of Santa Clara (U.S. exchange program, 2012)
- Brussels Bar
- Dutch, English, and French